These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6632177)
21. Sympathetic activity in borderline and established hypertension in the elderly. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB J Hypertens Suppl; 1988 Nov; 6(1):S55-8. PubMed ID: 3063795 [TBL] [Abstract][Full Text] [Related]
22. Enhanced acute antihypertensive effect of propranolol in the absence of circulating epinephrine in the rat. Burris JF; Waeber B; Nussberger J; Brunner HR J Cardiovasc Pharmacol; 1984; 6(4):697-700. PubMed ID: 6206328 [TBL] [Abstract][Full Text] [Related]
23. Effect of low-dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension. Houben H; Thien T; van 't Laar A Clin Pharmacol Ther; 1982 Jun; 31(6):685-90. PubMed ID: 6122527 [TBL] [Abstract][Full Text] [Related]
24. Blood pressure responses to catecholamines during beta-adrenergic blockade with propranolol in hypertensive subjects. Vlachakis ND; DeGuia D; Mendlowitz M Chest; 1977 Jan; 71(1):38-43. PubMed ID: 830497 [TBL] [Abstract][Full Text] [Related]
25. The baroreflex-mediated changes in plasma norepinephrine and heart rate in patients with essential hypertension. Ishizuka Y; Miura Y; Kimura S; Ohashi H; Sugawara T; Watanabe H; Noshiro T; Takahashi M; Sano N; Yoshinaga K Jpn Circ J; 1987 Oct; 51(10):1165-73. PubMed ID: 3430687 [TBL] [Abstract][Full Text] [Related]
26. Cardiac electrophysiologic effects of norepinephrine in human beings. Weiss R; Knight BP; Bahu M; Zivin A; Souza J; Goyal R; Daoud E; Man KC; Strickberger SA; Halter JB; Morady F Am Heart J; 1998 Jun; 135(6 Pt 1):945-51. PubMed ID: 9630097 [TBL] [Abstract][Full Text] [Related]
27. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects. Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922 [TBL] [Abstract][Full Text] [Related]
28. Calcium and blood pressure regulation in normal and hypertensive subjects. Bianchetti MG; Beretta-Piccoli C; Weidmann P; Link L; Boehringer K; Ferrier C; Morton JJ Hypertension; 1983; 5(4 Pt 2):II57-65. PubMed ID: 6345376 [TBL] [Abstract][Full Text] [Related]
29. Catecholamines, angiotensin II and sodium concentrations in cerebrospinal fluid in young men with borderline hypertension. Kawano Y; Fukiyama K; Takeya Y; Abe I; Omae T Clin Exp Hypertens A; 1984; 6(6):1131-45. PubMed ID: 6744640 [TBL] [Abstract][Full Text] [Related]
30. Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade. van den Meiracker AH; Man in 't Veld AJ; Boomsma F; Blankestijn PJ; Schalekamp MA J Cardiovasc Pharmacol; 1990 Apr; 15(4):610-7. PubMed ID: 1691392 [TBL] [Abstract][Full Text] [Related]
31. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors. Yorikane R; Kanda A; Kimura T; Satoh S J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122 [TBL] [Abstract][Full Text] [Related]
32. The influence of propranolol on the cardiovascular effects and plasma clearance of epinephrine. Ichinohe T; Igarashi O; Kaneko Y Anesth Prog; 1991; 38(6):217-20. PubMed ID: 1842159 [TBL] [Abstract][Full Text] [Related]
33. Plasma norepinephrine and epinephrine levels in essential hypertension. Goldstein DS; Lake CR Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339 [TBL] [Abstract][Full Text] [Related]
34. Plasma catecholamine levels in normal subjects and in patients with secondary hypertension. Lake CR; Chernow B; Goldstein DS; Glass DG; Coleman M; Ziegler MG Fed Proc; 1984 Jan; 43(1):52-6. PubMed ID: 6690338 [TBL] [Abstract][Full Text] [Related]
35. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms. Bouloux PM; Corsello S; Besser M; Grossman A Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322 [TBL] [Abstract][Full Text] [Related]
36. Glucoregulation during and after intense exercise: effects of beta-adrenergic blockade in subjects with type 1 diabetes mellitus. Sigal RJ; Fisher SJ; Halter JB; Vranic M; Marliss EB J Clin Endocrinol Metab; 1999 Nov; 84(11):3961-71. PubMed ID: 10566635 [TBL] [Abstract][Full Text] [Related]
37. Norepinephrine clearance and pressor effect in normal and hypertensive man. Grimm M; Weidmann P; Keusch G; Meier A; Glück Z Klin Wochenschr; 1980 Nov; 58(21):1175-81. PubMed ID: 7453102 [TBL] [Abstract][Full Text] [Related]
38. Blood pressure and norepinephrine spillover during propranolol infusion in humans. Best JD; Halter JB Am J Physiol; 1985 Apr; 248(4 Pt 2):R400-6. PubMed ID: 3985181 [TBL] [Abstract][Full Text] [Related]
39. Effect of beta-adrenergic blockade on circulating catecholamines and dopamine-beta-hydroxylase activity during exercise in normal subjects. Sheehan MW; Brammell HL; Sable DL; Nies AS; Horwitz LD Am Heart J; 1983 May; 105(5):777-82. PubMed ID: 6303097 [TBL] [Abstract][Full Text] [Related]
40. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity. Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]